Literature DB >> 6436309

Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.

D F Sahm, C N Baker, R N Jones, C Thornsberry.   

Abstract

The influence of culture medium of the MICs of eight cephalosporins for 45 strains of Streptococcus faecalis was investigated. The MICs of cephalothin, cefamandole, and cefoperazone were not substantially influenced by the type of culture medium used. In contrast, MICs of cefuroxime, ceftizoxime, cefotaxime, cefmenoxime, and ceftriaxone varied markedly with both the commercial brand and the blood content of the broth used. The use of Mueller-Hinton broths (from Oxoid Ltd., GIBCO Diagnostics, and Difco Laboratories) supplemented with 5% lysed sheep blood frequently resulted in MICs that were greater than or equal to 16 times lower than the MICs obtained with these same broths without blood. Similar, but less marked, patterns were observed when supplemented and unsupplemented brain heart infusion and Sceptor broths were used. The influence of the broth on MICs suggests a complex interaction between some cephalosporins, medium components, and organisms. The cephalosporins that were affected by media share an identical moiety at the 7-acyl position (cefuroxime is slightly different), but this structure is not shared by those cephalosporins that were not affected. This commonality in structure at the 7-acyl position may be partially responsible for the observed results.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436309      PMCID: PMC271370          DOI: 10.1128/jcm.20.3.561-567.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

2.  Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics.

Authors:  I W Fong; E R Engelking; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Cefuroxime, a new cephalosporin antibiotic: activity in vitro.

Authors:  C H O'Callaghan; R B Sykes; A Griffiths; J E Thornton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  Influence of different media and bloods on results of diffusion antibiotic susceptibility tests.

Authors:  V C Brenner; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

5.  Medium-dependent variation in bactericidal activity of antibiotics against susceptible Staphylococcus aureus.

Authors:  L R Peterson; D N Gerding; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

6.  HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

Authors:  H C Neu; N Aswapokee; P Aswapokee; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

7.  Hydrolysis of 3-acetoxymethyl cephalosporins by lysed whole blood.

Authors:  W E Wright; J A Frogge
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

8.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

9.  Regression curve analysis of cephalosporin activity.

Authors:  J A Washington; P K Yu
Journal:  Appl Microbiol       Date:  1970-04

10.  Effect of assay medium on the antibacterial activity of certain penicillins and cephalosporins.

Authors:  T A Pursiano; M Misiek; F Leitner; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

View more
  10 in total

1.  Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria.

Authors:  A L Barry; J L Cotton; R N Jones; R R Packer
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

2.  Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

3.  Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.

Authors:  A L Barry; R N Jones; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

4.  Impact of short perioperative courses of cefotaxime on aerobic bacterial flora in patients undergoing transurethral prostatic resection.

Authors:  M Grabe; A Forsgren
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

Review 5.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 6.  Mechanisms of resistance of enterococci to beta-lactam antibiotics.

Authors:  R Fontana; P Canepari; M M Lleò; G Satta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

7.  False susceptibility of enterococci to aminoglycosides with blood-enriched Mueller-Hinton agar for disk susceptibility testing.

Authors:  R D Jenkins; S L Stevens; J M Craythorn; T W Thomas; M E Guinan; J M Matsen
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

Review 8.  Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.

Authors:  R N Jones
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 9.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

10.  Effects of blood medium supplements on activities of newer cephalosporins tested against enterococci.

Authors:  B J Buschelman; R N Jones; M J Bale
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.